Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Mouse hepatitis virus infection upregulates genes involved in innate immune responses.
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort.
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Acute and subacute inflammation of the optic nerve and its sheath: clinical features in Chinese patients.
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance.
RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
Multiple Sclerosis Increases Fracture Risk: A Meta-Analysis.
Fingolimod induces neuroprotective factors in human astrocytes.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
In Vitro and In Vivo Models of Multiple Sclerosis.
Immunomodulatory therapies delay disease progression in multiple sclerosis.
Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy.
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

Pages